A citation-based method for searching scientific literature

Louise Wang, Heena Desai, Shefali S Verma, Anh Le, Ryan Hausler, Anurag Verma, Renae Judy, Abigail Doucette, Peter E Gabriel, Katherine L Nathanson, Scott M Damrauer, Danielle L Mowery, Marylyn D Ritchie, Rachel L Kember, Kara N Maxwell. Genet Med 2022
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Defining and Achieving Health Equity in Genomic Medicine.
Sonya Jooma, Michael J Hahn, Lucia A Hindorff, Vence L Bonham. Ethn Dis 2019
17
50

Insights into human genetic variation and population history from 929 diverse genomes.
Anders Bergström, Shane A McCarthy, Ruoyun Hui, Mohamed A Almarri, Qasim Ayub, Petr Danecek, Yuan Chen, Sabine Felkel, Pille Hallast, Jack Kamm,[...]. Science 2020
156
50

A standardized framework for representation of ancestry data in genomics studies, with application to the NHGRI-EBI GWAS Catalog.
Joannella Morales, Danielle Welter, Emily H Bowler, Maria Cerezo, Laura W Harris, Aoife C McMahon, Peggy Hall, Heather A Junkins, Annalisa Milano, Emma Hastings,[...]. Genome Biol 2018
75
50

A Custom Genotyping Array Reveals Population-Level Heterogeneity for the Genetic Risks of Prostate Cancer and Other Cancers in Africa.
Maxine Harlemon, Olabode Ajayi, Paidamoyo Kachambwa, Michelle S Kim, Corinne N Simonti, Melanie H Quiver, Desiree C Petersen, Anuradha Mittal, Pedro W Fernandez, Ann W Hsing,[...]. Cancer Res 2020
10
50

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.
David V Conti, Burcu F Darst, Lilit C Moss, Edward J Saunders, Xin Sheng, Alisha Chou, Fredrick R Schumacher, Ali Amin Al Olama, Sara Benlloch, Tokhir Dadaev,[...]. Nat Genet 2021
79
50

Genetic analyses of diverse populations improves discovery for complex traits.
Genevieve L Wojcik, Mariaelisa Graff, Katherine K Nishimura, Ran Tao, Jeffrey Haessler, Christopher R Gignoux, Heather M Highland, Yesha M Patel, Elena P Sorokin, Christy L Avery,[...]. Nature 2019
269
50

Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry.
Zhaohui Du, Guimin Gao, Babatunde Adedokun, Thomas Ahearn, Kathryn L Lunetta, Gary Zirpoli, Melissa A Troester, Edward A Ruiz-Narváez, Stephen A Haddad, Parichoy PalChoudhury,[...]. J Natl Cancer Inst 2021
11
50

Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer.
Anna Plym, Kathryn L Penney, Sarah Kalia, Peter Kraft, David V Conti, Christopher Haiman, Lorelei A Mucci, Adam S Kibel. J Natl Cancer Inst 2022
10
50

The Missing Diversity in Human Genetic Studies.
Giorgio Sirugo, Scott M Williams, Sarah A Tishkoff. Cell 2019
71
50

Genetic Hitchhiking and Population Bottlenecks Contribute to Prostate Cancer Disparities in Men of African Descent.
Joseph Lachance, Ali J Berens, Matthew E B Hansen, Andrew K Teng, Sarah A Tishkoff, Timothy R Rebbeck. Cancer Res 2018
35
50

Genomics is failing on diversity.
Alice B Popejoy, Stephanie M Fullerton. Nature 2016
671
50


Publisher Correction: Clinical use of current polygenic risk scores may exacerbate health disparities.
Alicia R Martin, Masahiro Kanai, Yoichiro Kamatani, Yukinori Okada, Benjamin M Neale, Mark J Daly. Nat Genet 2021
5
50

A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1.
S Bevan, T Pal, C R Greenberg, H Green, J Wixey, G Bignell, S A Narod, W D Foulkes, M R Stratton, R S Houlston. J Clin Endocrinol Metab 2001
53
50

A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2.
F Canzian, P Amati, H R Harach, J L Kraimps, F Lesueur, J Barbier, P Levillain, G Romeo, D Bonneau. Am J Hum Genet 1998
184
50


A new POT1 germline mutation-expanding the spectrum of POT1-associated cancers.
Tremika Le-Shan Wilson, Namita Hattangady, Antonio Marcondes Lerario, Carmen Williams, Erika Koeppe, Shane Quinonez, Jenae Osborne, Kelly B Cha, Tobias Else. Fam Cancer 2017
25
50

Increased Prevalence of Malignancies in Fibrous Dysplasia/McCune-Albright Syndrome (FD/MAS): Data from a National Referral Center and the Dutch National Pathology Registry (PALGA).
M Hagelstein-Rotman, M E Meier, B C J Majoor, A H G Cleven, P D S Dijkstra, N A T Hamdy, M A J van de Sande, O M Dekkers, N M Appelman-Dijkstra. Calcif Tissue Int 2021
4
50

The mystery of missing heritability: Genetic interactions create phantom heritability.
Or Zuk, Eliana Hechter, Shamil R Sunyaev, Eric S Lander. Proc Natl Acad Sci U S A 2012
918
50

Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.
Yu-Long Wang, Shou-Hao Feng, Shi-Cheng Guo, Wen-Jun Wei, Duan-Shu Li, Yu Wang, Xiaofeng Wang, Zhuo-Ying Wang, Yan-Yun Ma, Li Jin,[...]. J Med Genet 2013
59
50


Spectrum and risk of neoplasia in Werner syndrome: a systematic review.
Julia M Lauper, Alison Krause, Thomas L Vaughan, Raymond J Monnat. PLoS One 2013
118
50

Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations.
Julius Gudmundsson, Patrick Sulem, Daniel F Gudbjartsson, Jon G Jonasson, Asgeir Sigurdsson, Jon T Bergthorsson, Huiling He, Thorarinn Blondal, Frank Geller, Margret Jakobsdottir,[...]. Nat Genet 2009
291
50

MYH9 binds to lncRNA gene PTCSC2 and regulates FOXE1 in the 9q22 thyroid cancer risk locus.
Yanqiang Wang, Huiling He, Wei Li, John Phay, Rulong Shen, Lianbo Yu, Baris Hancioglu, Albert de la Chapelle. Proc Natl Acad Sci U S A 2017
52
50

An InDel in Phospholipase-C-B-1 Is Linked with Euthyroid Multinodular Goiter.
Ameen D Bakhsh, Ioannis Ladas, Marian L Hamshere, Martyn Bullock, George Kirov, Lei Zhang, Peter N Taylor, John W Gregory, David Scott-Coombes, Henry Völzke,[...]. Thyroid 2018
6
50

Frequency of Thyroid Carcinoma in Brazilian TP53 p.R337H Carriers With Li Fraumeni Syndrome.
Maria Nirvana da Cruz Formiga, Kelvin César de Andrade, Luiz Paulo Kowalski, Maria Isabel Achatz. JAMA Oncol 2017
12
50

The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl.
Meiko Takahashi, Vladimir A Saenko, Tatiana I Rogounovitch, Takahisa Kawaguchi, Valentina M Drozd, Hisako Takigawa-Imamura, Natallia M Akulevich, Chanavee Ratanajaraya, Norisato Mitsutake, Noboru Takamura,[...]. Hum Mol Genet 2010
121
50

Cancer risk in heterozygotes for ataxia-telangiectasia.
B Geoffroy-Perez, N Janin, K Ossian, A Laugé, M F Croquette, C Griscelli, M Debré, B Bressac-de-Paillerets, A Aurias, D Stoppa-Lyonnet,[...]. Int J Cancer 2001
96
50

Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations.
Veronika Mancikova, Raquel Cruz, Lucía Inglada-Pérez, Ceres Fernández-Rozadilla, Iñigo Landa, José Cameselle-Teijeiro, Catuxa Celeiro, Susana Pastor, Antonia Velázquez, Ricard Marcos,[...]. Int J Cancer 2015
32
50

Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer.
G R Bignell, F Canzian, M Shayeghi, M Stark, Y Y Shugart, P Biggs, J Mangion, R Hamoudi, J Rosenblatt, P Buu,[...]. Am J Hum Genet 1997
161
50

The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors.
Iñigo Landa, Sergio Ruiz-Llorente, Cristina Montero-Conde, Lucía Inglada-Pérez, Francesca Schiavi, Susanna Leskelä, Guillermo Pita, Roger Milne, Javier Maravall, Ignacio Ramos,[...]. PLoS Genet 2009
124
50

NOP53 as A Candidate Modifier Locus for Familial Non-Medullary Thyroid Cancer.
Aida Orois, Sudheer K Gara, Mireia Mora, Irene Halperin, Sandra Martínez, Rocio Alfayate, Electron Kebebew, Josep Oriola. Genes (Basel) 2019
11
50

A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24.
Huiling He, Rebecca Nagy, Sandya Liyanarachchi, Hong Jiao, Wei Li, Saul Suster, Juha Kere, Albert de la Chapelle. Cancer Res 2009
117
50

Disruption of a novel gene, DIRC3, and expression of DIRC3-HSPBAP1 fusion transcripts in a case of familial renal cell cancer and t(2;3)(q35;q21).
Daniëlle Bodmer, Marga Schepens, Marc J Eleveld, Eric F P M Schoenmakers, Ad Geurts van Kessel. Genes Chromosomes Cancer 2003
29
50

Segregation and expression analyses of hyaluronan-binding protein 2 (HABP2): insights from a large series of familial non-medullary thyroid cancers and literature review.
Carla Colombo, Marina Muzza, Maria Carla Proverbio, Giulia Ercoli, Michela Perrino, Valentina Cirello, Leonardo Vicentini, Stefano Ferrero, Laura Fugazzola. Clin Endocrinol (Oxf) 2017
12
50

Risk of cancer by ATM missense mutations in the general population.
Sarah Louise Dombernowsky, Maren Weischer, Kristine Højgaard Allin, Stig Egil Bojesen, Anne Tybjaerg-Hansen, Børge Grønne Nordestgaard. J Clin Oncol 2008
54
50



Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma.
Feng Ye, Hongwei Gao, Lin Xiao, Zhixiang Zuo, Yueping Liu, Qi Zhao, Huijiao Chen, Weiyi Feng, Bo Fu, Linyong Sun,[...]. Int J Cancer 2019
25
50

Mechanisms of neuregulin action.
David A Talmage. Novartis Found Symp 2008
46
50

Ataxia telangiectasia: a review.
Cynthia Rothblum-Oviatt, Jennifer Wright, Maureen A Lefton-Greif, Sharon A McGrath-Morrow, Thomas O Crawford, Howard M Lederman. Orphanet J Rare Dis 2016
242
50

The p.G534E variant of HABP2 is not associated with sporadic papillary thyroid carcinoma in a Polish population.
Artur Kowalik, Danuta Gąsior-Perczak, Martyna Gromek, Monika Siołek, Agnieszka Walczyk, Iwona Pałyga, Małgorzata Chłopek, Janusz Kopczyński, Ryszard Mężyk, Aldona Kowalska,[...]. Oncotarget 2017
11
50

Clinicopathological features and prognosis of familial papillary thyroid carcinoma--a large-scale, matched, case-control study.
Jun Cao, Can Chen, Chao Chen, Qing-Liang Wang, Ming-Hua Ge. Clin Endocrinol (Oxf) 2016
19
50

DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome.
Ingrid Slade, Chiara Bacchelli, Helen Davies, Anne Murray, Fatemeh Abbaszadeh, Sandra Hanks, Rita Barfoot, Amos Burke, Julia Chisholm, Martin Hewitt,[...]. J Med Genet 2011
210
50

Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer?
Kinga Hińcza, Artur Kowalik, Iwona Pałyga, Agnieszka Walczyk, Danuta Gąsior-Perczak, Estera Mikina, Tomasz Trybek, Monika Szymonek, Klaudia Gadawska-Juszczyk, Klaudia Zajkowska,[...]. Cancers (Basel) 2020
3
50

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
S Filetti, C Durante, D Hartl, S Leboulleux, L D Locati, K Newbold, M G Papotti, A Berruti. Ann Oncol 2019
211
50

Discovery of common variants associated with low TSH levels and thyroid cancer risk.
Julius Gudmundsson, Patrick Sulem, Daniel F Gudbjartsson, Jon G Jonasson, Gisli Masson, Huiling He, Aslaug Jonasdottir, Asgeir Sigurdsson, Simon N Stacey, Hrefna Johannsdottir,[...]. Nat Genet 2012
162
50

Identification of Unique, Heterozygous Germline Mutation, STK11 (p.F354L), in a Child with an Encapsulated Follicular Variant of Papillary Thyroid Carcinoma within Six Months of Completing Treatment for Neuroblastoma.
Melissa A Buryk, Jennifer L Picarsic, Susan E Creary, Peter H Shaw, Jeffrey P Simons, Melvin Deutsch, Sara E Monaco, Yuri E Nikiforov, Selma Feldman Witchel. Pediatr Dev Pathol 2015
13
50

NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.
Robert I Haddad, Christian Nasr, Lindsay Bischoff, Naifa Lamki Busaidy, David Byrd, Glenda Callender, Paxton Dickson, Quan-Yang Duh, Hormoz Ehya, Whitney Goldner,[...]. J Natl Compr Canc Netw 2018
131
50

Ultra-rare mutation in long-range enhancer predisposes to thyroid carcinoma with high penetrance.
Huiling He, Wei Li, Dayong Wu, Rebecca Nagy, Sandya Liyanarachchi, Keiko Akagi, Jaroslaw Jendrzejewski, Hong Jiao, Kevin Hoag, Bernard Wen,[...]. PLoS One 2013
26
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.